Novartis
Novartis to buy breast cancer drug candidate from Synnovation in up to $3 billion deal
By Axel Miller | 20 Mar 2026
Novartis will acquire a breast cancer drug candidate from Synnovation Therapeutics in a deal worth up to $3 billion, boosting its oncology pipeline.
Novartis India refutes media reports of negotiations with Alkem Labs
27 Sep 2024
Novartis India, has refuted media reports stating that its parent company is in talks with Mumbai-based Alkem Labs for sale of the Indian arm.
Siemens Healthineers submits binding offer for Novartis’s molecular imaging business
27 Aug 2024
Siemens Healthiness AG is reported to have submitted a binding offer for acquiring the molecular imaging business of Swiss Drugmaker Novartis.
Novartis to acquire US-based Mariana Oncology in $1.75 bn deal
03 May 2024
Swiss drug maker Novartis has agreed to acquire US-based Mariana Oncology in a deal worth $1.75 billion, as the company seeks advance the development of precision treatment for cancer.
Novartis announces strategic review of its India business
19 Feb 2024
Swiss pharma multinational Novartis AG has started a strategic review of its Indian arm, possibly with the intent of selling it off.
